Graduate Students in Pharmacogenomics Research

Graduate student candidates must possess a strong background in genetics, pharmacology, or related field. Successful post-doctoral candidates must hold a Ph.D. in genomics, genetics, medical genetics, pharmacology, or related field and possess up-to-date knowledge about genomic analysis tools and technologies. The CMMT includes outstanding infrastructure support and core facilities.

Abstract:

Description:

Dr. Michael Hayden and Dr. Colin Ross at the Centre for Molecular Medicine and Therapeutics (www.cmmt.ubc.ca) at the University of British Columbia in Vancouver, B.C., are seeking applications for Graduate Students and Postdoctoral Fellows in pharmacogenomics research. Successful candidates will join the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) to identify the genetic determinants of severe adverse drug reactions (ADRs). CPNDS is an energetic, nation-wide, multidisciplinary consortium of researchers and clinicians from hospitals, universities, and research institutes that was established to improve drug safety. CPNDS has catalyzed national and international collaborations and established an active surveillance network to identify patients that have suffered severe ADRs across Canada. The research program applies innovative, large-scale genotyping and DNA sequencing strategies to identify the genetic factors of severe ADRs and to develop diagnostic tests for safer personalized medicine.

Exceptional candidates should send:
1) CV in PDF format
2) the names of 2 references
3) a brief statement of research interests (1/4-1/2 page)
to: dng@cmmt.ubc.ca, Centre for Molecular Medicine & Therapeutics, 980 W. 28th Ave, Vancouver, BC V5Z 4H4.

Deadline: 02-04-2011

Contacts:

Email: dng@cmmt.ubc.ca

If you apply for this position please say you saw it on eurizons.eu

Eurizon.eu

Search

Last Insert

Graduate Students in Pharmacogenomics Research

Contacts: